Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952751640> ?p ?o ?g. }
- W2952751640 abstract "Glioma is the most common and lethal type of malignant brain tumor. Accumulating evidence has highlighted that RNA binding protein APOBEC1 complementation factor (A1CF) is involved in various cellular processes by modulating RNA expression, and acts as an oncogene in breast cancer. However, the function of A1CF in glioma remained unclear.Quantitative RT-PCR and western blot analysis were employed to detect the expression levels of A1CF, lncRNA family with sequence similarity 224 member A (FAM224A), miR-590-3p, zinc finger protein 143 (ZNF143) and ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 (ASAP3) in glioma tissues and cell lines. The Cell Counting Kit-8 assay, migration and invasion assays, and flow cytometry analysis were conducted to evaluate the function of A1CF, FAM224A, miR-590-3p, ZNF143 and ASAP3 in the malignant biological behaviors of glioma cells. Moreover, luciferase reporter, RIP and ChIP assays were used to investigate the interactions among A1CF, FAM224A, miR-590-3p, ZNF143, ASAP3 and MYB. Finally, the xenograft tumor growth assay further ascertained the biological roles of A1CF, FAM224A and miR-590-3p in glioma cells.A1CF was upregulated and functioned as an oncogene via stabilizing and increasing FAM224A expression; moreover, high A1CF and FAM224A expression levels indicated a poorer prognosis for glioma patients. Conversely, miR-590-3p was downregulated and exerted a tumor-suppressive function in glioma cells. Inhibition of A1CF significantly restrained cell proliferation, migration and invasion, and promoted apoptosis by upregulating miR-590-3p in a FAM224A-dependent manner. FAM224A was a molecular sponge of miR-590-3p and they were in an RNA-induced silencing complex. ZNF143 was upregulated in glioma tissues and cell lines. MiR-590-3p could negatively modulate the expression of ZNF143 via binding to the ZNF143 3' UTR. Moreover, ZNF143 participated in miR-590-3p-induced tumor-suppressive activity on glioma cells. ASAP3 and MYB were transcriptionally activated by ZNF143, and importantly, ZNF143 could directly target the promoter of FAM224A and stimulate its expression, collectively forming a positive feedback loop.The present study clarifies that the A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop conducts critical regulatory effects on the malignant progression of glioma cells, which provides a novel molecular target for glioma therapy." @default.
- W2952751640 created "2019-06-27" @default.
- W2952751640 creator A5003253320 @default.
- W2952751640 creator A5036905517 @default.
- W2952751640 creator A5042251722 @default.
- W2952751640 creator A5052198607 @default.
- W2952751640 creator A5063350238 @default.
- W2952751640 creator A5064488623 @default.
- W2952751640 creator A5066430213 @default.
- W2952751640 creator A5073562160 @default.
- W2952751640 creator A5076498350 @default.
- W2952751640 creator A5081344725 @default.
- W2952751640 creator A5085563830 @default.
- W2952751640 date "2019-06-11" @default.
- W2952751640 modified "2023-10-15" @default.
- W2952751640 title "Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells" @default.
- W2952751640 cites W1972248141 @default.
- W2952751640 cites W1984574291 @default.
- W2952751640 cites W1988105651 @default.
- W2952751640 cites W1989057528 @default.
- W2952751640 cites W1996923969 @default.
- W2952751640 cites W1997107674 @default.
- W2952751640 cites W1999882409 @default.
- W2952751640 cites W2002456707 @default.
- W2952751640 cites W2017358094 @default.
- W2952751640 cites W2034500416 @default.
- W2952751640 cites W2067807852 @default.
- W2952751640 cites W2074327714 @default.
- W2952751640 cites W2076950591 @default.
- W2952751640 cites W2078277807 @default.
- W2952751640 cites W2082698120 @default.
- W2952751640 cites W2089613496 @default.
- W2952751640 cites W2094266374 @default.
- W2952751640 cites W2103437467 @default.
- W2952751640 cites W2121316093 @default.
- W2952751640 cites W2130687298 @default.
- W2952751640 cites W2138769440 @default.
- W2952751640 cites W2146573461 @default.
- W2952751640 cites W2147638644 @default.
- W2952751640 cites W2151252501 @default.
- W2952751640 cites W2154033106 @default.
- W2952751640 cites W2207064026 @default.
- W2952751640 cites W2325777483 @default.
- W2952751640 cites W2341857169 @default.
- W2952751640 cites W2395015275 @default.
- W2952751640 cites W2476629295 @default.
- W2952751640 cites W2498795244 @default.
- W2952751640 cites W2560385907 @default.
- W2952751640 cites W2560793024 @default.
- W2952751640 cites W2586093186 @default.
- W2952751640 cites W2588339892 @default.
- W2952751640 cites W2591308199 @default.
- W2952751640 cites W2593764350 @default.
- W2952751640 cites W2600155138 @default.
- W2952751640 cites W2613281665 @default.
- W2952751640 cites W2659689178 @default.
- W2952751640 cites W2718277692 @default.
- W2952751640 cites W2735357018 @default.
- W2952751640 cites W2752304808 @default.
- W2952751640 cites W2756099564 @default.
- W2952751640 cites W2767955698 @default.
- W2952751640 cites W2774081006 @default.
- W2952751640 cites W2782959626 @default.
- W2952751640 cites W2789588319 @default.
- W2952751640 cites W2793017340 @default.
- W2952751640 cites W2800469107 @default.
- W2952751640 cites W2801494164 @default.
- W2952751640 cites W2886226517 @default.
- W2952751640 doi "https://doi.org/10.1186/s13046-019-1200-5" @default.
- W2952751640 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6558706" @default.
- W2952751640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31186064" @default.
- W2952751640 hasPublicationYear "2019" @default.
- W2952751640 type Work @default.
- W2952751640 sameAs 2952751640 @default.
- W2952751640 citedByCount "19" @default.
- W2952751640 countsByYear W29527516402020 @default.
- W2952751640 countsByYear W29527516402021 @default.
- W2952751640 countsByYear W29527516402022 @default.
- W2952751640 countsByYear W29527516402023 @default.
- W2952751640 crossrefType "journal-article" @default.
- W2952751640 hasAuthorship W2952751640A5003253320 @default.
- W2952751640 hasAuthorship W2952751640A5036905517 @default.
- W2952751640 hasAuthorship W2952751640A5042251722 @default.
- W2952751640 hasAuthorship W2952751640A5052198607 @default.
- W2952751640 hasAuthorship W2952751640A5063350238 @default.
- W2952751640 hasAuthorship W2952751640A5064488623 @default.
- W2952751640 hasAuthorship W2952751640A5066430213 @default.
- W2952751640 hasAuthorship W2952751640A5073562160 @default.
- W2952751640 hasAuthorship W2952751640A5076498350 @default.
- W2952751640 hasAuthorship W2952751640A5081344725 @default.
- W2952751640 hasAuthorship W2952751640A5085563830 @default.
- W2952751640 hasBestOaLocation W29527516401 @default.
- W2952751640 hasConcept C104317684 @default.
- W2952751640 hasConcept C127561419 @default.
- W2952751640 hasConcept C153911025 @default.
- W2952751640 hasConcept C190283241 @default.
- W2952751640 hasConcept C24284526 @default.
- W2952751640 hasConcept C2778227246 @default.
- W2952751640 hasConcept C2781018059 @default.
- W2952751640 hasConcept C29537977 @default.